메뉴 건너뛰기




Volumn 77, Issue 1-2, 2001, Pages 77-86

Possibility of the reversal of multidrug resistance and the avoidance of side effects by liposomes modified with MRK-16, a monoclonal antibody to P-glycoprotein

Author keywords

Cancer chemotherapy; Liposome; Multidrug resistance; P Glycoprotein; Side effect

Indexed keywords

DOXORUBICIN; GLYCOPROTEIN P; IMMUNOGLOBULIN G2A; IMMUNOLIPOSOME; MONOCLONAL ANTIBODY MRK 16; VERAPAMIL; VINCRISTINE;

EID: 0035834268     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-3659(01)00460-6     Document Type: Article
Times cited : (52)

References (26)


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.